‹ All Posts
Kavan Patel

1 hour ago · SEBI Registration INH000006174

AARTI PHARMALABS LIMITED (INVESTMENT OPPORTUNITY)

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals Business Overview: Aarti Pharmalabs Ltd, formerly known as Aarti Organics, was a Wholly Owned Subsidiary of Aarti Industries Limited. It got demerged in Oct'22 into a separately listed entity. Currently, the company is an internationally recognized manufacturer of generic API & Intermediates, Xanthine derivatives, and offers CDMO /CMO services. The company has 6 manufacturing plants and 3 R&D centres. Market Share The company has a 15-20% Global Market Share in Xanthine RATIONALE: As we can see AARTI PHARMALABS LTD is our investment pick with bullish view. In chart we can see that stock has given breakout of rounding bottom price patten with heavy volume. One can buy AARTI PHARMALABS LTD with 1 year view and strict stop-loss of 950 with potential target of 1150. AARTIPHARM

#TechnicalViews#EquityResearch#WatchOutFor
AARTI PHARMA.pdf
13 likes·14 comments